Trials / Completed
CompletedNCT00389220
Limus Eluted From A Durable Versus ERodable Stent Coating
A Randomized Comparison of a Biolimus-Eluting Stent With a Sirolimus-Eluting Stent for Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,707 (actual)
- Sponsor
- Biosensors Europe SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the BioMatrix Flex (Biolimus A9-Eluting) stent system with the Cypher SELECT (Sirolimus-Eluting) stent system in a non-inferiority trial.
Detailed description
Compare the safety and efficacy of the BioMatrix Flex (Biolimus A9-Eluting) stent system with the Cypher SELECT (Sirolimus-Eluting) stent system in a prospective, multi-center, randomized, controlled, non-inferiority trial in patients undergoing percutaneous coronary intervention in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Coronary stent placement | Coronary stent placement |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-05-01
- Completion
- 2012-06-01
- First posted
- 2006-10-18
- Last updated
- 2019-05-07
Locations
10 sites across 7 countries: Belgium, France, Germany, Netherlands, Poland, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00389220. Inclusion in this directory is not an endorsement.